Похоже, при загрузке страницы произошла ошибка.
Наша команда получила уведомление. Если проблема сохранится, свяжитесь с нами через виджет поддерж. по email.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | -0,2x - -0,2x | -0,2x |
| Selected Fwd EBITDA Multiple | 4,4x - 4,8x | 4,6x |
| Fair Value | 2.294₩ - 2.346₩ | 2.320₩ |
| Upside | -11,1% - -9,1% | -10,1% |
| Benchmarks | Ticker | Full Ticker |
| INSAN Inc. | A277410 | KOSDAQ:A277410 |
| Genic Co., Ltd. | A123330 | KOSDAQ:A123330 |
| Outin Futures Co., Ltd | A227610 | KOSDAQ:A227610 |
| Icure Pharmaceutical Incorporation | A175250 | KOSDAQ:A175250 |
| Cosmecca Korea Co., Ltd. | A241710 | KOSDAQ:A241710 |
| Medience Co., Ltd. | A014100 | KOSDAQ:A014100 |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| A277410 | A123330 | A227610 | A175250 | A241710 | A014100 | ||
| KOSDAQ:A277410 | KOSDAQ:A123330 | KOSDAQ:A227610 | KOSDAQ:A175250 | KOSDAQ:A241710 | KOSDAQ:A014100 | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | -12.9% | 21.1% | NM- | NM- | 25.0% | NM- | |
| 3Y CAGR | -34.8% | NM- | NM- | NM- | 28.9% | NM- | |
| Latest Twelve Months | -63.7% | 445.1% | -202.2% | -5.5% | 18.6% | -4138.6% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 21.3% | 0.5% | -14.7% | -23.2% | 9.9% | 1.2% | |
| Prior Fiscal Year | 21.0% | -7.9% | 4.8% | -31.8% | 14.0% | 0.3% | |
| Latest Fiscal Year | 8.8% | 15.4% | -4.6% | -32.9% | 14.9% | -15.2% | |
| Latest Twelve Months | 8.8% | 15.4% | -4.6% | -29.5% | 14.9% | -15.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 1.92x | 3.50x | 1.18x | 1.13x | 1.21x | 0.11x | |
| EV / LTM EBITDA | 21.9x | 22.8x | -25.5x | -3.8x | 8.1x | -0.7x | |
| EV / LTM EBIT | 76.5x | 29.0x | -11.9x | -2.6x | 10.5x | -0.6x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | -25.5x | 8.1x | 22.8x | ||||
| Historical EV / LTM EBITDA | -22.7x | 3.4x | 11.3x | ||||
| Selected EV / LTM EBITDA | -0.2x | -0.2x | -0.2x | ||||
| (x) LTM EBITDA | (7,438) | (7,438) | (7,438) | ||||
| (=) Implied Enterprise Value | 1,202 | 1,265 | 1,328 | ||||
| (-) Non-shareholder Claims * | 20,316 | 20,316 | 20,316 | ||||
| (=) Equity Value | 21,518 | 21,581 | 21,644 | ||||
| (/) Shares Outstanding | 11.3 | 11.3 | 11.3 | ||||
| Implied Value Range | 1,904.12 | 1,909.71 | 1,915.31 | ||||
| FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 1,904.12 | 1,909.71 | 1,915.31 | 2,580.00 | |||
| Upside / (Downside) | -26.2% | -26.0% | -25.8% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | A277410 | A123330 | A227610 | A175250 | A241710 | A014100 | |
| Enterprise Value | 62,480 | 176,402 | 42,102 | 70,444 | 653,894 | 8,840 | |
| (+) Cash & Short Term Investments | 12,537 | 1,290 | 8,129 | 22,492 | 64,440 | 4,791 | |
| (+) Investments & Other | 2,180 | 0 | 1,611 | 8,091 | 2,736 | 31,960 | |
| (-) Debt | (30,882) | (5,940) | (23,526) | (37,728) | (122,405) | (16,435) | |
| (-) Other Liabilities | (329) | 0 | 2,312 | (696) | (89,229) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | (2,624) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 45,986 | 171,752 | 30,627 | 59,978 | 509,436 | 29,156 | |
| (/) Shares Outstanding | 37.7 | 7.8 | 35.4 | 37.4 | 10.7 | 11.3 | |
| Implied Stock Price | 1,220.00 | 21,950.00 | 864.00 | 1,605.00 | 47,700.00 | 2,580.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 1,220.00 | 21,950.00 | 864.00 | 1,605.00 | 47,700.00 | 2,580.00 | |
| Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |